The present invention relates to medical apparatus and procedures. More particularly, the present invention relates to an apparatus and method for detection of disconnection in an extracorporeal blood circuit being used for any blood processing treatment routine.
Vascular access for establishing an extracorporeal blood circuit is typically obtained by using a trans-dermal needle or a luer connected catheter. Usually blood processing treatment routines require establishment of extracorporeal blood circuits. Examples of blood processing treatment routines include continual renal replacement therapy such as hemodialysis wherein blood flows outside a patient's body via a set of tubes, commonly known as arterial supply line, to a dialyzer (artificial kidney) which removes waste products and excess fluids from it. Uncontaminated blood, then, flows back into the patient's body via a second set of tubes commonly referred to as venous return line.
An extracorporeal blood circuit might be disrupted while a blood processing treatment routine is in progress due to disconnection of a needle or a catheter providing vascular access. Such disruption may have serious and often fatal consequences. Needles corresponding to an arterial supply line or a venous return line of a blood circuit may disconnect due to numerous reasons, including the sudden movement of the patient undergoing the blood processing treatment. Disconnection of a supply line is relatively easy to detect by monitoring air in the supply line. In circumstances where a supply line disconnection remains undetected for some time, generally, only a slight blood loss occurs, which is equivalent to that caused by a small needle wound.
Disconnection of venous return line of an extracorporeal blood circuit is a much more alarming occurrence. The blood flow rate in most blood processing treatment routines such as hemodialysis is very high, typically around 300-400 ml/min. Hence, a disconnection of a venous return line results in blood being pumped out of a patient's body at a rapid rate. Multiple liters of hemorrhaging within a few minutes lead to serious injury and may cause death, if not detected and remedied immediately.
Detection of a return line disconnect is difficult, as most known methods are based on monitoring and detecting a change in pressure in the venous return line tubing. Return line disconnection usually occurs due to a needle pull out situation. Since, a needle typically offers the highest fluidic resistance in an extracorporeal blood circuit, a pressure change in the return line due to needle disconnect is not significant and cannot be detected easily. The pressure drop is also very low in cases where a catheter disconnects from a patient's body, causing a return line disconnection.
Hence, detection of a disconnection in a return venous blood circuit using pressure as an indicator or metric is unreliable and may result in serious injury. Further, methods using detection of air bubbles as an indication of a disconnect cannot be relied upon because a disconnect in a venous return line does not cause air to be drawn in the return line tubing.
One known method uses a detection of moisture at a needle site to detect the disconnection of a venous return line of an extracorporeal blood circuit. The method is based on an assumption that a needle pull out would cause a blood leak, thereby making the needle site wet. Various moisture sensing methods are available for use in the detection of moisture at a needle site. One such method employs optical spectrophotometry and another employs electrical conductivity measurement for moisture detection.
Moisture sensing methods require an additional apparatus, such as sensor elements to be fastened to a patient's body near the needle site. Further, such methods are based on the assumption that, after a needle pull, blood is pooled near the sensor element. However, in situations where the needle pull out is caused by a violent action, such as sudden rolling over of the patient while sleeping, the needle may cause blood flow at a distance from the sensor element. Hence, in such a situation, the moisture sensing method would provide a false negative and, at approximately 300 ml/min blood flow rate, excessive blood loss would occur in only a couple of minutes.
Another known method uses detection of certain signals from a patient's body for detection of disconnection of venous return line. This method detects changes in signals which are attributable to a needle pull out from a patient's body. One method measures electrical signals of a patient's heart through a return venous line of an extracorporeal blood circuit of the patient. In a needle pull out situation, the electrical signals are no longer detectable. This method takes advantage of the fact that blood is a good electrical conductor and the electrical signals generated by the patient's beating heart are conducted through blood carrying tubes as long as the extracorporeal blood circuit is unbroken.
However, the method fails in situations where a needle pull out occurs causing bleeding but the return venous line is intact due to fluid contact with the pool of blood. Also, efficiency of the method decreases due to the fact that the electrical activity of heart provides a very small electrical signal which, in a noisy electrical background, yields a low signal to noise ratio. Hence, loss of the signal or a failure to distinguish it from a noisy background may cause a false positive reading.
Consequently, there is need for an improved apparatus and method for detecting a disconnect in a venous return line. Further, there is also need for an apparatus and method which does not require any extra element, such as a moisture pad to be placed at the needle insertion site. Hence, there is need for an apparatus and method for detecting a disconnect in a venous return line of an extra corporeal blood circuit, which is reliable and reduces the probability the disconnection remaining undetected and causing fatal consequences.
The present invention is directed to a dialysis system having a disconnection monitor for determining if a blood line connection to a patient has been disconnected, comprising: a blood circuit in fluid communication with a patient and a dialysis circuit; a pressure transducer in pressure communication with the blood circuit wherein the pressure transducer generates a signal indicative of a pulse signal in the blood circuit; a cardiac reference signal generator, wherein the cardiac reference signal generator detects and generates a signal indicative of the patient's pulse and a disconnection monitor. The disconnection monitor comprises a pressure transducer data receiver, wherein the pressure transducer data receiver receives the signal indicative of the pulse signal in the blood circuit; a cardiac reference signal receiver, wherein the cardiac reference signal receiver receives the signal indicative of the patient's pulse; and a processor, wherein the processor cross-correlates the signal indicative of the pulse signal in the blood circuit and the signal indicative of the patient's pulse to generate data indicative of a disconnection of the blood line connection to the patient.
Optionally, the dialysis system comprises a controller, wherein the controller triggers an alarm based upon the data indicative of a disconnection of the blood line connection to the patient. Optionally, the dialysis system comprises a controller, wherein the controller shuts down a dialysis pump based upon the data indicative of a disconnection of the blood line connection to the patient. The pressure transducer non-invasively generates a signal indicative of a pulse signal in the blood circuit. Optionally, along the length of the blood line to the patient, the pressure transducer is separated from the patient by a pinch valve and an air bubble detector.
Optionally, the cardiac reference signal generator is a pulse oximeter. Optionally, the processor cross-correlates the signal indicative of the pulse signal in the blood circuit and the signal indicative of the patient's pulse by computing a sum of products of corresponding pairs of points of the signal indicative of the pulse signal in the blood circuit and the signal indicative of the patient's pulse within a specified time frame. The dialysis system comprises programmatic instructions for directing a patient to first attach said cardiac signal reference generator prior to starting a dialysis pump. The dialysis system comprises programmatic instructions for directing the system to capture the signal indicative of the pulse signal in said blood circuit prior to starting a dialysis pump. The processor comprises an amplifier.
In another embodiment, the present invention is directed toward a dialysis system having a manifold in data communication with a disconnection monitor for determining if a blood line connection to a patient has been disconnected, comprising the disposable manifold having a blood circuit in fluid communication with a patient and a dialysis circuit; a pressure transducer integrated within the manifold and in non-invasive pressure communication with the blood circuit wherein the pressure transducer generates a signal indicative of a pulse signal in the blood circuit; a cardiac reference signal generator, wherein the cardiac reference signal generator detects and generates a signal indicative of the patient's pulse and the disconnection monitor. The disconnection monitor comprises a pressure transducer data receiver, wherein the pressure transducer data receiver receives the signal indicative of the pulse signal in the blood circuit; a cardiac reference signal receiver, wherein the cardiac reference signal receiver receives the signal indicative of the patient's pulse; and a processor, wherein the processor cross-correlates the signal indicative of the pulse signal in the blood circuit and the signal indicative of the patient's pulse to generate data indicative of a disconnection of the blood line connection to the patient.
Optionally, the dialysis system further comprises a controller, wherein the controller triggers an alarm based upon the data indicative of a disconnection of the blood line connection to the patient. The dialysis system further comprises a controller, wherein the controller shuts down a dialysis pump based upon the data indicative of a disconnection of the blood line connection to the patient. The pressure transducer non-invasively generates a signal indicative of a pulse signal in the blood circuit and wirelessly communicates the signal indicative of a pulse signal in said blood circuit to the pressure transducer data receiver. Optionally, the dialysis system, along the length of the blood line to the patient, the pressure transducer is separated from the patient by a pinch valve and an air bubble detector. Optionally, the cardiac reference signal generator is a pulse oximeter and wirelessly communicates the signal indicative of the patient's pulse to the cardiac reference signal receiver.
Optionally, the processor cross-correlates the signal indicative of the pulse signal in the blood circuit and the signal indicative of the patient's pulse by computing a sum of products of corresponding pairs of points of the signal indicative of the pulse signal in the blood circuit and the signal indicative of the patient's pulse within a specified time frame. Optionally, the dialysis system comprises programmatic instructions for directing a patient to first attach said cardiac signal reference generator prior to starting a dialysis pump. Optionally, the dialysis system comprises programmatic instructions for directing the system to capture said signal indicative of the pulse signal in said blood circuit prior to starting a dialysis pump. Optionally, the processor comprises an amplifier.
The present invention is described by way of embodiments illustrated in the accompanying drawings wherein:
The present invention describes an apparatus and method for detection of disconnection in an extracorporeal blood circuit being used for any blood processing treatment routine. Examples of blood processing treatment routines include hemodialysis, hemofiltration, ultrafiltration, apheresis, etc. Vascular access for establishing an extracorporeal blood circuit is typically obtained by using a transdermal needle or a luer connected catheter. The apparatus and method described in the present invention uses the pressure pulse produced by a patient's beating heart as an indicator of an intact needle or catheter connection to the vasculature. The pressure pulse produced by a patient's heart is small; more so, in the venous return line of an extracorporeal blood circuit. In order to detect the small pressure pulse the present invention uses cross correlation methodology wherein a reference cardiac signal is cross correlated to the pressure pulse signal.
The following disclosure is provided in order to enable a person having ordinary skill in the art to practice the invention. Exemplary embodiments are provided only for illustrative purposes and various modifications will be readily apparent to persons skilled in the art. The general principles defined herein may be applied to other embodiments and applications without departing from the spirit and scope of the invention. Also, the terminology and phraseology used is for the purpose of describing exemplary embodiments and should not be considered limiting. Thus, the present invention is to be accorded the widest scope encompassing numerous alternatives, modifications and equivalents consistent with the principles and features disclosed. For purpose of clarity, details relating to technical material that is known in the technical fields related to the invention have not been described in detail so as not to unnecessarily obscure the present invention.
The present invention will now be discussed in context of embodiments as illustrated in the accompanying drawings.
It should be appreciated that any suitable dialysis circuit can be deployed. In one preferred embodiment, the dialysis circuit 106 is embodied in a dialysis manifold, as disclosed, in U.S. patent application Ser. No. 12/324,924, filed on Nov. 28, 2008, which has been incorporated herein by reference. In one embodiment, the dialyzer 104 is equivalent to dialyzer 430 of FIG. 4 in U.S. patent application Ser. No. 12/324,924, the venous blood circuit is equivalent to the patient return line of FIG. 4 in U.S. patent application Ser. No. 12/324,924, and the patient pulse pressure transducer is incorporated proximate to Port H 422 of the manifold, such as at pressure transducer 407.
The pressure transducer 108 measures the pressure pulse of a patient undergoing the blood processing treatment routine and communicates the pulse pressure substantially continuously to the disconnect monitor 120. In one embodiment the transducer 108 is an invasive or non-invasive venous pressure sensor located anywhere in the dialysis blood line (the incoming arterial blood circuit 102 or the return venous blood circuit 110). In another embodiment, the transducer 108 is an invasive or non-invasive venous pressure sensor located specifically in a dialysis blood line between the dialyzer 104 and the patient, that is, in the return venous blood circuit 110. A non-invasive air bubble detector and/or pinch valve (not shown) are optionally located between the transducer 108 and the luer connection to the patient. In an embodiment of the present invention, the pressure transducer 108 is located in close proximity to the needle or catheter inserted in the patient's body for providing vascular access corresponding to the return venous blood circuit 110. The pressure transducer 108 is located in close proximity to the needle or catheter in order to preserve waveform fidelity. In other embodiments, the pressure transducer 108 may be connected anywhere in the return venous blood circuit 110. In an embodiment of the present invention, the pressure signal produced by the pressure transducer 108 is an alternating current (AC) signal which is not an accurate measure of vascular pressure. Hence, the pressure transducer 108 is not a high accuracy transducer.
The reference signal generator 115 communicates the patient's cardiac signal substantially continuously to the disconnect monitor 120 for reference. In an embodiment of the present invention, the reference cardiac signal is obtained from a plethysmograph connected to the same body part (such as an arm) to which the needle or catheter supplying processed blood to a patient is connected. In another embodiment of the present invention, the reference cardiac signal is obtained from a finger pulse sensor/oximeter. In various other embodiments of the present invention, the reference cardiac signal may be obtained an electro-cardiogram (ECG) signal, a real time blood pressure signal, stethoscope, arterial pressure signal from the blood withdrawal line, oximeter pulse signal, alternate site plethysmograph signal, transmissive and/or reflective plethysmograph signals, acoustic cardiac signals, wrist pulse or from any other cardiac signal source known to persons of ordinary skill in the art.
The disconnect monitor 120 detects a disruption in the return venous blood circuit 110 caused by the disconnection of a needle or catheter, from the body of a patient undergoing blood processing treatment. To detect a disconnection, the monitor 120 processes the patient pulse pressure transducer and cardiac reference signals. Persons of ordinary skill in the art would appreciate that such disconnection may be caused by the needle or catheter being pulled out of the patient's body due to any reason such as a sudden movement of the patient. The disconnect monitor 108 is described in detail with reference to
Persons of ordinary skill in the art should appreciate that the pressure transducer and reference signals are communicated to the disconnect monitor 120 through transmitters incorporated into the reference signal generator and pressure transducer. The transmitter can enable a wired or wireless communication to a corresponding receiver. Similarly, data from the disconnect monitor 120 is communicated to the controller 125 through wired or wireless connection. In one embodiment, such signal communication is enabled using an appropriate wired or wireless public and/or private network such as LAN, WAN, MAN, Bluetooth networks, and/or the Internet. Also, in one embodiment the disconnect monitor 120 and controller 125 are located in proximity to each other and to the pressure transducer 108 and the cardiac reference signal generator 115. In an alternate embodiment, both or either of the disconnect monitor 120 and the controller 125 are/is located remotely from each other and/or from the rest of the components of the system 100.
The pressure pulse signal obtained by the pressure transducer receiver 202 and the reference cardiac signal obtained by the reference signal receiver 204 are stored in a local memory and further fed to the cross correlation processor 206, which in turn, computes a correlation between the two signals. The output of the processor 206 is fed into the controller 125 of
Persons of ordinary skill in the art should note that the present invention envisages use of any cross correlation processor that links, corresponds, or otherwise creates a measurable, quantifiable, and/or predictable relationship between the pressure transducer signal and reference signal. In one embodiment of the present invention cross correlation is performed by using a lock in amplifier, such as SR 810 Lock In Amplifier manufactured by Stanford Research Systems, California. Various known techniques for cross correlation detection of very low signal to noise ratio systems, and cardiac signals may be incorporated in the cross correlation processor 206.
In various embodiments of the present invention, the cross correlation function, computed by the cross correlation processor 206, is used to measure the similarities between the two input signals, i.e. the reference cardiac signal and the pressure pulse signal. Computation of the cross correlation function comprises computation of a sum of the products of corresponding pairs of points of the two input signals, within a specified time frame or window. The computation also takes into consideration any potential phase differences between the two input signals by including a lead or lag term. The mathematical formula corresponding to a cross correlation function is represented as:
where N represents a number of samples, j represents a lag factor and x1 and x2 represent the two input signals respectively.
However, if a correlation is obtained, then that correlation is substantially continually monitored 325. If there is any deviation in that correlation, an alarm is triggered 330, indicating a possible leak or, optionally, the system is shut down (completely or partially) and an attempt to re-establish the correlated signal is attempted again. In one embodiment, if the nature of the correlation change or deviates beyond or within a predefined threshold, certain system components, such as pumps, are shut down and the cross correlation processor attempts to re-establish the correlation. If the correlation cannot be re-established, then an alarm is triggered. In another embodiment, if the nature of the correlation change or deviates beyond or outside the range of a predefined threshold, certain system components, such as pumps, are shut down and an alarm is immediately triggered, before any additional attempt to re-establish the correlation.
The present invention provides certain distinct improvements over the prior art. First, unlike the prior art, the present invention is responsive if the needle is just barely pulled out or if it is removed and pulled quite some distance from the insertion site. Second, the present invention does not need any extra apparatus placed at the insertion site, such as a moisture pad. Third, by cross correlating the patients' own cardiac signal, the false negatives are greatly diminished. Fourth, the combination of pressure pulse sensing and cross correlation renders the present invention unique and capable of detecting low signal to noise ratio signals. Fifth, continuously monitoring the cross correlation status enables the system to detect small signal deviations which could potentially indicate a disconnection. Therefore, an apparatus and method for detection of disconnection in an extracorporeal blood circuit being used for any blood processing treatment routine, is provided by the present invention.
While the exemplary embodiments of the present invention are described and illustrated herein, it will be appreciated that they are merely illustrative. It will be understood by those skilled in the art that various changes in form and detail may be made therein without departing from or offending the spirit and scope of the invention.
The present invention relies on U.S. Patent Provisional No. 61/151,912 filed on Feb. 12, 2009 for priority. The present invention is also related to a) U.S. patent application Ser. No. 12/575,450, filed on Oct. 7, 2009, b) U.S. patent application Ser. No. 12/575,449, filed on Oct. 7, 2009, c) U.S. patent application Ser. No. 12/355,102, filed on Jan. 16, 2009, d) U.S. patent application Ser. No. 12/355,128, filed on Jan. 16, 2009, e) U.S. patent application Ser. No. 12/351,969, filed on Jan. 12, 2009, f) U.S. patent application Ser. No. 12/324,924, filed on Nov. 28, 2008, g) U.S. patent application Ser. No. 12/210,080, filed on Sep. 12, 2008, h) U.S. patent application Ser. No. 12/238,055, filed on Sep. 25, 2008, i) U.S. patent application Ser. No. 12/237,914, filed on Sep. 25, 2008, j) U.S. patent application Ser. No. 12/249,090, filed on Oct. 10, 2008, k) U.S. patent application Ser. No. 12/245,397, filed on Oct. 3, 2008, l) U.S. patent application Ser. No. 12/610,032, filed on Oct. 30, 2009, and m) U.S. patent application Ser. No. 12/610,100, filed on Oct. 30, 2009. All of the aforementioned applications are herein incorporated by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 2328381 | Jaffe | Aug 1943 | A |
| 4071444 | Ash et al. | Jan 1978 | A |
| 4083777 | Hutchisson | Apr 1978 | A |
| 4113614 | Rollo et al. | Sep 1978 | A |
| 4348283 | Ash | Sep 1982 | A |
| 4368737 | Ash | Jan 1983 | A |
| 4387777 | Ash | Jun 1983 | A |
| 4397189 | Johnson et al. | Aug 1983 | A |
| 4402694 | Ash et al. | Sep 1983 | A |
| 4403984 | Ash et al. | Sep 1983 | A |
| 4413988 | Handt et al. | Nov 1983 | A |
| 4469593 | Ishihara et al. | Sep 1984 | A |
| 4477342 | Allan et al. | Oct 1984 | A |
| 4498902 | Ash et al. | Feb 1985 | A |
| 4559039 | Ash et al. | Dec 1985 | A |
| 4581141 | Ash | Apr 1986 | A |
| 4596550 | Troutner | Jun 1986 | A |
| 4599055 | Dykstra | Jul 1986 | A |
| 4606826 | Sano et al. | Aug 1986 | A |
| 4661246 | Ash | Apr 1987 | A |
| 4666598 | Heath et al. | May 1987 | A |
| 4680122 | Barone | Jul 1987 | A |
| 4683053 | Polaschegg | Jul 1987 | A |
| 4740755 | Ogawa | Apr 1988 | A |
| 4762618 | Gummesson et al. | Aug 1988 | A |
| 4777953 | Ash et al. | Oct 1988 | A |
| 4854322 | Ash et al. | Aug 1989 | A |
| 4861242 | Finsterwald | Aug 1989 | A |
| 4909713 | Finsterwald et al. | Mar 1990 | A |
| 4914819 | Ash | Apr 1990 | A |
| 4950244 | Fellingham et al. | Aug 1990 | A |
| 4990258 | Bjare et al. | Feb 1991 | A |
| 4995268 | Ash et al. | Feb 1991 | A |
| 4997570 | Polaschegg | Mar 1991 | A |
| 5002054 | Ash et al. | Mar 1991 | A |
| 5011607 | Shinzato | Apr 1991 | A |
| 5032261 | Pyper | Jul 1991 | A |
| 5100554 | Polaschegg | Mar 1992 | A |
| 5114580 | Ahmad et al. | May 1992 | A |
| 5147613 | Heilmann et al. | Sep 1992 | A |
| 5198335 | Sekikawa et al. | Mar 1993 | A |
| 5211643 | Reinhardt et al. | May 1993 | A |
| 5230341 | Polaschegg | Jul 1993 | A |
| 5277820 | Ash | Jan 1994 | A |
| 5295505 | Polaschegg et al. | Mar 1994 | A |
| 5304349 | Polaschegg | Apr 1994 | A |
| 5308315 | Khuri et al. | May 1994 | A |
| 5322519 | Ash | Jun 1994 | A |
| 5385005 | Ash | Jan 1995 | A |
| D355816 | Ash | Feb 1995 | S |
| 5405315 | Khuri et al. | Apr 1995 | A |
| 5441636 | Chevallet et al. | Aug 1995 | A |
| 5445630 | Richmond | Aug 1995 | A |
| 5460493 | Deniega et al. | Oct 1995 | A |
| 5476444 | Keeling et al. | Dec 1995 | A |
| D370531 | Ash et al. | Jun 1996 | S |
| 5536412 | Ash | Jul 1996 | A |
| 5540265 | Polaschegg et al. | Jul 1996 | A |
| 5577891 | Loughnane et al. | Nov 1996 | A |
| 5580460 | Polaschegg | Dec 1996 | A |
| 5614677 | Wamsiedler et al. | Mar 1997 | A |
| 5616305 | Mathieu | Apr 1997 | A |
| 5624551 | Baumann et al. | Apr 1997 | A |
| 5629871 | Love et al. | May 1997 | A |
| 5632897 | Mathieu | May 1997 | A |
| 5644285 | Maurer | Jul 1997 | A |
| 5674390 | Matthews et al. | Oct 1997 | A |
| 5679245 | Manica | Oct 1997 | A |
| 5693008 | Brugger et al. | Dec 1997 | A |
| 5698083 | Glass | Dec 1997 | A |
| 5711883 | Folden et al. | Jan 1998 | A |
| 5713850 | Heilmann et al. | Feb 1998 | A |
| 5725773 | Polaschegg | Mar 1998 | A |
| 5744027 | Connell et al. | Apr 1998 | A |
| 5782796 | Din et al. | Jul 1998 | A |
| 5794669 | Polaschegg et al. | Aug 1998 | A |
| 5858186 | Glass | Jan 1999 | A |
| 5906978 | Ash | May 1999 | A |
| 5919369 | Ash | Jul 1999 | A |
| 5945343 | Munkholm | Aug 1999 | A |
| 5947953 | Ash et al. | Sep 1999 | A |
| 5951870 | Utterberg | Sep 1999 | A |
| 5989423 | Kamen et al. | Nov 1999 | A |
| 5989438 | Fumiyama | Nov 1999 | A |
| 6042561 | Ash et al. | Mar 2000 | A |
| 6086753 | Ericson et al. | Jul 2000 | A |
| 6156007 | Ash | Dec 2000 | A |
| 6190349 | Ash et al. | Feb 2001 | B1 |
| 6217540 | Yazawa et al. | Apr 2001 | B1 |
| 6234989 | Brierton et al. | May 2001 | B1 |
| 6254567 | Treu et al. | Jul 2001 | B1 |
| 6264680 | Ash | Jul 2001 | B1 |
| 6280406 | Dolecek et al. | Aug 2001 | B1 |
| 6284131 | Hogard et al. | Sep 2001 | B1 |
| 6287516 | Matson et al. | Sep 2001 | B1 |
| 6303036 | Collins et al. | Oct 2001 | B1 |
| 6332985 | Sherman et al. | Dec 2001 | B1 |
| 6348162 | Ash | Feb 2002 | B1 |
| 6409699 | Ash | Jun 2002 | B1 |
| 6416293 | Bouchard et al. | Jul 2002 | B1 |
| 6468427 | Frey | Oct 2002 | B1 |
| 6471872 | Kitaevich et al. | Oct 2002 | B2 |
| 6497675 | Davankov | Dec 2002 | B1 |
| 6551513 | Nikaido et al. | Apr 2003 | B2 |
| 6554789 | Brugger et al. | Apr 2003 | B1 |
| 6572576 | Brugger et al. | Jun 2003 | B2 |
| 6572641 | Brugger et al. | Jun 2003 | B2 |
| 6579253 | Brugger et al. | Jun 2003 | B1 |
| 6579460 | Willis et al. | Jun 2003 | B1 |
| 6582385 | Brugger et al. | Jun 2003 | B2 |
| 6589482 | Brugger et al. | Jul 2003 | B1 |
| 6595943 | Burbank | Jul 2003 | B1 |
| 6623470 | Munis et al. | Sep 2003 | B2 |
| 6627164 | Wong | Sep 2003 | B1 |
| 6638477 | Treu et al. | Oct 2003 | B1 |
| 6638478 | Treu et al. | Oct 2003 | B1 |
| 6649063 | Brugger et al. | Nov 2003 | B2 |
| 6653841 | Koerdt et al. | Nov 2003 | B1 |
| 6673314 | Burbank et al. | Jan 2004 | B1 |
| 6695803 | Robinson et al. | Feb 2004 | B1 |
| 6702561 | Stillig et al. | Mar 2004 | B2 |
| 6730266 | Matson et al. | May 2004 | B2 |
| 6743193 | Brugger et al. | Jun 2004 | B2 |
| 6764460 | Dolecek et al. | Jul 2004 | B2 |
| 6773412 | O'Mahony et al. | Aug 2004 | B2 |
| 6818196 | Wong | Nov 2004 | B2 |
| 6830553 | Burbank et al. | Dec 2004 | B1 |
| 6841172 | Ash | Jan 2005 | B1 |
| 6852090 | Burbank et al. | Feb 2005 | B2 |
| 6872346 | Stillig | Mar 2005 | B2 |
| 6878283 | Thompson | Apr 2005 | B2 |
| 6899691 | Bainbridge et al. | May 2005 | B2 |
| 6923782 | O'Mahony et al. | Aug 2005 | B2 |
| 6955655 | Burbank et al. | Oct 2005 | B2 |
| 6958049 | Ash | Oct 2005 | B1 |
| 6960179 | Gura | Nov 2005 | B2 |
| 6960328 | Bortun et al. | Nov 2005 | B2 |
| 6979309 | Burbank et al. | Dec 2005 | B2 |
| 7004924 | Brugger et al. | Feb 2006 | B1 |
| 7033498 | Wong | Apr 2006 | B2 |
| 7040142 | Burbank | May 2006 | B2 |
| 7087033 | Brugger et al. | Aug 2006 | B2 |
| 7101519 | Wong | Sep 2006 | B2 |
| 7112273 | Weigel et al. | Sep 2006 | B2 |
| 7115095 | Eigler et al. | Oct 2006 | B2 |
| 7135156 | Hai et al. | Nov 2006 | B2 |
| 7144386 | Korkor et al. | Dec 2006 | B2 |
| 7147613 | Burbank et al. | Dec 2006 | B2 |
| 7169303 | Sullivan et al. | Jan 2007 | B2 |
| 7175809 | Gelfand et al. | Feb 2007 | B2 |
| 7214312 | Brugger et al. | May 2007 | B2 |
| 7226538 | Brugger et al. | Jun 2007 | B2 |
| 7241272 | Karoor et al. | Jul 2007 | B2 |
| 7252767 | Bortun et al. | Aug 2007 | B2 |
| 7267658 | Treu et al. | Sep 2007 | B2 |
| 7273465 | Ash | Sep 2007 | B2 |
| 7276042 | Polaschegg et al. | Oct 2007 | B2 |
| 7300413 | Burbank et al. | Nov 2007 | B2 |
| 7309323 | Gura et al. | Dec 2007 | B2 |
| 7337674 | Burbank et al. | Mar 2008 | B2 |
| 7338460 | Burbank et al. | Mar 2008 | B2 |
| 7347849 | Brugger et al. | Mar 2008 | B2 |
| 7494590 | Felding et al. | Feb 2009 | B2 |
| 7648476 | Bock et al. | Jan 2010 | B2 |
| 7713226 | Ash et al. | May 2010 | B2 |
| 7780619 | Brugger et al. | Aug 2010 | B2 |
| 7794141 | Perry et al. | Sep 2010 | B2 |
| 7873489 | Dolgos et al. | Jan 2011 | B2 |
| 7886611 | O'Mahony et al. | Feb 2011 | B2 |
| 7901376 | Steck et al. | Mar 2011 | B2 |
| 7922898 | Jonsson et al. | Apr 2011 | B2 |
| 7922899 | Vasta et al. | Apr 2011 | B2 |
| 7981280 | Carr et al. | Jul 2011 | B2 |
| 7998101 | Ash | Aug 2011 | B2 |
| 8021319 | Delnevo et al. | Sep 2011 | B2 |
| 8034235 | Rohde et al. | Oct 2011 | B2 |
| 8062513 | Yu et al. | Nov 2011 | B2 |
| 8066658 | Karoor et al. | Nov 2011 | B2 |
| 8070707 | Gelfand et al. | Dec 2011 | B2 |
| 8075509 | Molducci et al. | Dec 2011 | B2 |
| 8078333 | Kienman et al. | Dec 2011 | B2 |
| 8105260 | Tonelli et al. | Jan 2012 | B2 |
| 20020068364 | Arai et al. | Jun 2002 | A1 |
| 20020085951 | Gelfand et al. | Jul 2002 | A1 |
| 20030128125 | Burbank et al. | Jul 2003 | A1 |
| 20050070837 | Ferrarini et al. | Mar 2005 | A1 |
| 20050131332 | Kelly et al. | Jun 2005 | A1 |
| 20050133439 | Blickhan | Jun 2005 | A1 |
| 20060122552 | O'Mahony | Jun 2006 | A1 |
| 20070112297 | Plahey et al. | May 2007 | A1 |
| 20070158249 | Ash | Jul 2007 | A1 |
| 20070158268 | DeComo | Jul 2007 | A1 |
| 20070161113 | Ash | Jul 2007 | A1 |
| 20070213654 | Lundtveit et al. | Sep 2007 | A1 |
| 20080041136 | Kopelman et al. | Feb 2008 | A1 |
| 20080041792 | Crnkovich et al. | Feb 2008 | A1 |
| 20080065006 | Roger et al. | Mar 2008 | A1 |
| 20080149563 | Ash | Jun 2008 | A1 |
| 20080195021 | Roger et al. | Aug 2008 | A1 |
| 20080195060 | Roger et al. | Aug 2008 | A1 |
| 20080230450 | Burbank et al. | Sep 2008 | A1 |
| 20090079578 | Dvorsky et al. | Mar 2009 | A1 |
| 20090080757 | Roger et al. | Mar 2009 | A1 |
| 20090082646 | Bouton | Mar 2009 | A1 |
| 20090082647 | Busby | Mar 2009 | A1 |
| 20090082649 | Muller et al. | Mar 2009 | A1 |
| 20090082653 | Rohde | Mar 2009 | A1 |
| 20090082676 | Bennison | Mar 2009 | A1 |
| 20090095679 | Demers et al. | Apr 2009 | A1 |
| 20090105627 | Rohde | Apr 2009 | A1 |
| 20090113335 | Sandoe et al. | Apr 2009 | A1 |
| 20090312694 | Bedingfield et al. | Dec 2009 | A1 |
| 20100312161 | Jonsson et al. | Dec 2010 | A1 |
| 20100326916 | Wrazel et al. | Dec 2010 | A1 |
| 20110000830 | Ikeda | Jan 2011 | A1 |
| 20110009799 | Mullick et al. | Jan 2011 | A1 |
| 20110028881 | Basaglia | Feb 2011 | A1 |
| 20110028882 | Basaglia | Feb 2011 | A1 |
| 20110041928 | Volker | Feb 2011 | A1 |
| 20110046533 | Stefani et al. | Feb 2011 | A1 |
| 20110054352 | Ko et al. | Mar 2011 | A1 |
| 20110092907 | Krogh et al. | Apr 2011 | A1 |
| 20110093294 | Elahi et al. | Apr 2011 | A1 |
| 20110098545 | Ross et al. | Apr 2011 | A1 |
| 20110098624 | McCotter et al. | Apr 2011 | A1 |
| 20110098625 | Masala et al. | Apr 2011 | A1 |
| 20110098635 | Helmore et al. | Apr 2011 | A1 |
| 20110105877 | Wilt et al. | May 2011 | A1 |
| 20110105981 | Wagner et al. | May 2011 | A1 |
| 20110105983 | Kelly et al. | May 2011 | A1 |
| 20110105984 | Patel et al. | May 2011 | A1 |
| 20110106002 | Helmore et al. | May 2011 | A1 |
| 20110106047 | Burbank et al. | May 2011 | A1 |
| 20110106466 | Furmanski et al. | May 2011 | A1 |
| 20110107251 | Guaitoli et al. | May 2011 | A1 |
| 20110108482 | Lovell | May 2011 | A1 |
| 20110125073 | Rambod et al. | May 2011 | A1 |
| 20110126714 | Brugger et al. | Jun 2011 | A1 |
| 20110132838 | Curtis et al. | Jun 2011 | A1 |
| 20110132841 | Rohde et al. | Jun 2011 | A1 |
| 20110137224 | Ibragimov | Jun 2011 | A1 |
| 20110137264 | Chelak | Jun 2011 | A1 |
| 20110139704 | Choi et al. | Jun 2011 | A1 |
| 20110140896 | Menzel | Jun 2011 | A1 |
| 20110141116 | Dalesch et al. | Jun 2011 | A1 |
| 20110152739 | Roncadi et al. | Jun 2011 | A1 |
| 20110155657 | Collins et al. | Jun 2011 | A1 |
| 20110160649 | Pan | Jun 2011 | A1 |
| 20110166507 | Childers et al. | Jul 2011 | A1 |
| 20110168614 | Pouchoulin et al. | Jul 2011 | A1 |
| 20110171713 | Bluchel et al. | Jul 2011 | A1 |
| 20110189048 | Curtis et al. | Aug 2011 | A1 |
| 20110208072 | Pfeiffer et al. | Aug 2011 | A1 |
| 20110208106 | Levin et al. | Aug 2011 | A1 |
| 20110213289 | Toyoda et al. | Sep 2011 | A1 |
| 20110218475 | Brugger et al. | Sep 2011 | A1 |
| 20110218487 | Shang et al. | Sep 2011 | A1 |
| 20110226680 | Jonsson et al. | Sep 2011 | A1 |
| 20110230814 | Kopperschmidt et al. | Sep 2011 | A1 |
| 20110237997 | Beden et al. | Sep 2011 | A1 |
| 20110237998 | Wariar et al. | Sep 2011 | A1 |
| 20110240537 | Ferrarini et al. | Oct 2011 | A1 |
| 20110240555 | Ficheux et al. | Oct 2011 | A1 |
| 20110269167 | Bene | Nov 2011 | A1 |
| 20110272352 | Braig | Nov 2011 | A1 |
| 20110275984 | Biewer et al. | Nov 2011 | A1 |
| 20110284464 | Roncadi et al. | Nov 2011 | A1 |
| 20110297593 | Kelly et al. | Dec 2011 | A1 |
| 20110297598 | Lo et al. | Dec 2011 | A1 |
| 20110297599 | Lo et al. | Dec 2011 | A1 |
| 20110300010 | Jarnagin et al. | Dec 2011 | A1 |
| 20110300230 | Peterson et al. | Dec 2011 | A1 |
| 20110303588 | Kelly et al. | Dec 2011 | A1 |
| 20110303590 | Childers et al. | Dec 2011 | A1 |
| 20110303598 | Lo et al. | Dec 2011 | A1 |
| 20110309019 | Ahrens | Dec 2011 | A1 |
| 20110315611 | Fulkerson et al. | Dec 2011 | A1 |
| 20120010554 | Vantard et al. | Jan 2012 | A1 |
| 20120018377 | Tsukamoto | Jan 2012 | A1 |
| 20120018378 | Kelly et al. | Jan 2012 | A1 |
| 20120022440 | Childers et al. | Jan 2012 | A1 |
| 20120029324 | Akonur et al. | Feb 2012 | A1 |
| 20120029937 | Neftel et al. | Feb 2012 | A1 |
| 20120031826 | Childers et al. | Feb 2012 | A1 |
| 20120035534 | Yu et al. | Feb 2012 | A1 |
| 20120037550 | Childers et al. | Feb 2012 | A1 |
| 20120043279 | Kelly et al. | Feb 2012 | A1 |
| 20120065567 | Zarate | Mar 2012 | A1 |
| 20120075266 | Shimizu et al. | Mar 2012 | A1 |
| Number | Date | Country |
|---|---|---|
| 2009073567 | Jun 2009 | WO |
| 2010114932 | Jul 2010 | WO |
| Entry |
|---|
| Renal Solutions, Inc., “The Allient Sorbent Hemodialysis System Operator Manual”, RSI Part No. 207460, Revision C, 2008. |
| Reyes et al., “Acid-Base Derangements During Sorbent Regenerative Hemodialysis in Mechanically Ventilated Patients”, Critical Care Medicine, vol. 19, No. 4, 1991, 554-559 (col. 2, lines 17-22). |
| Fresenius AG, “Acumen Acute Dialysis Machine Operating Instructions”, Version 1.0, May 1996. |
| Cobe Laboratories, Inc., “CentrySystem 3 Dialysis Control Unit Operators Manual”, Sep. 1988. |
| Renal Solutions, Inc., “The Allient Sorbent Hemodialysis System Home User Manual”, 2006. |
| Renal Solutions, Inc., “The Allient Sorbent Hemodialysis System Operator Manual”, RSI Part No. 206948, Revision G, 2008. |
| Fresenius USA, Inc., “Fresenius 2008H Hemodialysis Machine”, Part No. 490005, Revision H, 1994-2001. |
| Renal Solutions, Inc., 510(K) for the SORB+ and HISORB+ Cartridges, Mar. 31, 2003. |
| CD Medical, Inc., “Operator's Manual Drake Willock 480 Ultrafiltration Control Single Patient Delivery System”, 1988. |
| Renal Solutions, Inc., “Dialysate Tubing Set and Dialysate Reservoir Bag for the Allient Sorbent Hemodialysis System”, Instructions, 2004. |
| NxStage Medical, Inc., “NxStage System One User's Guide”, Software Version 4.3, Part 1 through Part 6-20, 2006. |
| NxStage Medical, Inc., “NxStage System One User's Guide”, Software Version 4.3, Part 6-20 through Part C-17, 2006. |
| Renal Solutions, Inc., 510K for the Allient Sorbent Hemodialysis System, Dec. 17, 2004. |
| Manns et al., “The acu-men: A New Device for Continuous Renal Replacement Therapy in Acute Renal Failure”, Kidney International, vol. 54 (1998), 268-274. |
| REDY® 2000 Operator's Manual (1991) (Sorbent cartridge-based hemodialysis system). |
| REDY® 2000 Service Manual (1989) (Sorbent cartridge-based hemodialysis system). |
| Seratron™ Dialysis Control System Operations Manual (cumulative 1980). |
| Ward et al., “Sorbent Dialysis Regenerated Dialysis Delivery Systems”, Peritoneal Dialysis Bulletin, Chapter 8, 3(2): S41-S48 (Apr.-Jun. 1983). |
| Anthony J. Wing et al., “Dialysate Regeneration”, Replacement of Renal Function by Dialysis, Chapter 17, 323-340 (William Drukker et al., eds., Martinus Nijhoff Publishers, 2nd ed., 1983). |
| Fresenius AG, “Acumen Acute Dialysis Machine Brief Operating Instructions”, May 1996. |
| Renal Solutions, Special 510(k) Device Modification, Allient Sorbent Hemodialysis System, Mar. 15, 2007. |
| Renal Solutions, 510(K), Allient Sorbent Hemodialysis System, Dec. 2004. |
| Renal Solutions, Inc., Portions of 510(k) Allient Sorbent Hemodialysis System (Sections A-I), Dec. 17, 2004. |
| Renal Solutions, Inc., Portions of 510(k) Allient Sorbent Hemodialysis System (Allient Main Controller Software Architecture Overview), Renal Solutions, Inc., Dec. 17, 2004. |
| Renal Solutions, Inc., Portions of 510(k) Allient Sorbent Hemodialysis System (Sections M.3 and M.4), Renal Solutions, Inc., Dec. 17, 2004. |
| Fresenius USA, Inc., Portions of Operator's Manual, Fresenius 2008H, Hemodialysis Machine, (Section 1), 2001, pp. 1-27. |
| Fresenius USA, Inc., Portions of Operator's Manual, Fresenius 2008H, Hemodialysis Machine, (Sections 2.1 to 2.6), 2001, pp. 29-54. |
| Fresenius USA, Inc., Portions of Operator's Manual, Fresenius 2008H, Hemodialysis Machine, (Sections 2.8 to 2.15), 2001, pp. 55-75. |
| Renal Solutions, Portions of the Allient Sorbent Hemodialysis System, Home User Manual, 2006, Chapters 1-3. |
| Renal Solutions, Portions of the Allient Sorbent Hemodialysis System, Home User Manual, 2006, Chapters 4. |
| Renal Solutions, Portions of the Allient Sorbent Hemodialysis System, Home User Manual, 2006, Chapters 5 to end. |
| Renal Solutions, Portions of the Allient Sorbent Hemodialysis System, Operator Manual, 2008, Chapters 1 to 2. |
| Renal Solutions, Portions of the Allient Sorbent Hemodialysis System, Operator Manual, 2008, Chapter 3. |
| Renal Solutions, Portions of the Allient Sorbent Hemodialysis System, Operator Manual, 2008, Chapter 4, 4-1 to 4-33. |
| Renal Solutions, Portions of the Allient Sorbent Hemodialysis System, Operator Manual, 2008, Chapter 4, 4-34 to 4-69. |
| Renal Solutions, Portions of the Allient Sorbent Hemodialysis System, Operator Manual, 2008, Chapter 5. |
| Renal Solutions, Portions of the Allient Sorbent Hemodialysis System, Operator Manual Model 1500, 2008, Chapters 1 to 2. |
| Renal Solutions, Portions of the Allient Sorbent Hemodialysis System, Operator Manual Model 1500, 2008, Chapter 3, 3-2 to 3-30. |
| Renal Solutions, Portions of the Allient Sorbent Hemodialysis System, Operator Manual Model 1500, 2008, Chapter 3, 3-31 to 3-70. |
| Number | Date | Country | |
|---|---|---|---|
| 20100234786 A1 | Sep 2010 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61151912 | Feb 2009 | US |